Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **microbial lipid bilayer** refers to the double-layered structure of amphipathic lipids that forms the fundamental permeability barrier of bacterial, archaeal, and some eukaryotic microbial cells[1][3][5][7]. It consists primarily of phospholipids (such as phosphatidylglycerol, phosphatidylethanolamine, and cardiolipin) organized in two sheets with hydrophobic tails inward and hydrophilic heads outward[3][5][7]. The bilayer provides a selectively permeable barrier, supports the membrane potential, anchors proteins and receptors involved in transport and signaling, and, in bacteria, is a major determinant of sensitivity to antibiotics that act by membrane disruption such as polymyxins and daptomycin[5][7]. While it is a critical structural and functional element, it is not considered a single molecular "target" in the traditional sense (e.g., distinct receptor or enzyme), but rather a class of structures susceptible to some drugs[3]. Modifications, such as changes in lipid composition or biophysical properties, play a key role in microbial resistance to environmental stress and antimicrobials[6][7]. Additional context: - **Not a single target:** "Microbial lipid bilayer" does not refer to a single protein or small molecule entity but broadly encompasses the entire lipid-based membrane structure[1][3]. - **Therapeutic targeting:** Some antimicrobial drugs act directly on the membrane, but specificity and toxicity are notable challenges, as human cellular membranes have similar structural features, particularly in the case of polymyxins[5][7]. - **Aliases:** Commonly referred to as "bacterial membrane," "bacterial lipid bilayer," or "microbial membrane"[5][7]. **Summary:** "Microbial lipid bilayer" is not a discrete, canonical drug target like a defined protein or receptor; it is a structural feature of all microbes and serves as a physicochemical barrier and site of antimicrobial drug action, but it does not have an official abbreviation or specific alias signifying a unique molecular target[1][3][7].
Disruption of membrane integrity (detergent-like effect); Increased membrane permeability leading to cell lysis; Formation of pores or channels; Binding to lipid A/LPS (for Gram-negative bacteria)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial lipid bilayer.